(17-(CYCLOPROPYLMETHYL)-4,5-EPOXY-14-HYDROXY-3-(((TRIFLUOROMETHYL)SULFONYL)OXY)-(5.ALPHA.)-MORPHINAN-6-ONE CYCLIC 1,2-ETHANEDIYL ACETAL
UNII 6XZ2R5HW2F
Substance Identification & Data
This profile provides standardized clinical and technical data for (17-(cyclopropylmethyl)-4,5-epoxy-14-hydroxy-3-(((trifluoromethyl)sulfonyl)oxy)-(5.alpha.)-morphinan-6-one Cyclic 1,2-ethanediyl Acetal, uniquely identified by the FDA Unique Ingredient Identifier (UNII) 6XZ2R5HW2F.
Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 263713-00-4 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.
Detailed Substance Profile
C23H26F3NO7S OTUZCXHDGTXHKO-RZXSNQJFSA-N Synonyms and Nomenclature
This section provides a complete list of nomenclature and identifier mappings for (17-(cyclopropylmethyl)-4,5-epoxy-14-hydroxy-3-(((trifluoromethyl)sulfonyl)oxy)-(5.alpha.)-morphinan-6-one Cyclic 1,2-ethanediyl Acetal. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.